Introduction:

The pharmaceutical industry in India has emerged as one of the largest and most significant sectors in the country. With a rich history and a strong manufacturing base, India has become a global hub for pharmaceutical production and research. The industry contributes significantly to the Indian economy and plays a crucial role in providing affordable healthcare solutions to both domestic and international markets.

In recent years, there has been a noticeable surge in the interest of entrepreneurs and investors looking to start pharmaceutical businesses in India. The country's growing population, rising healthcare needs, and favorable business environment have attracted individuals and organizations seeking opportunities in this sector. However, entering and navigating the pharmaceutical industry requires a deep understanding of the regulatory landscape.

The purpose of this article is to shed light on the regulatory landscape for starting pharmaceutical businesses in India. It aims to provide aspiring entrepreneurs and investors with an overview of the regulations, licensing requirements, drug approval processes, intellectual property rights, pricing mechanisms, and compliance standards that govern the industry. By understanding and navigating the regulatory landscape, individuals can make informed decisions, ensure legal compliance, and establish successful pharmaceutical ventures in India.

Understanding the Regulatory Landscape for Pharma Businesses in India

Importance of Regulatory Compliance:

Regulatory compliance plays a crucial role in the pharmaceutical industry for several reasons. Understanding the regulatory landscape and adhering to the relevant regulations is essential for starting a pharmaceutical business and ensuring its long-term success. Here are some key points highlighting the importance of regulatory compliance:

· Safety and Quality Assurance: Regulatory compliance helps ensure the safety and efficacy of pharmaceutical products. By adhering to regulations, businesses can implement robust quality control measures, follow Good Manufacturing Practices (GMP), and maintain strict standards for product safety. This not only protects the health and well-being of consumers but also enhances the reputation and credibility of the business.

· Legal Compliance: The pharmaceutical industry is heavily regulated to protect public health and prevent unethical practices. Understanding and complying with the regulatory framework helps businesses avoid legal issues, penalties, and potential shutdowns. Compliance with licensing requirements, drug approval processes, intellectual property rights, and pricing regulations is crucial for operating within the boundaries of the law.

· Market Access: Regulatory compliance is often a prerequisite for market access. Many regulatory authorities require businesses to fulfill specific criteria and obtain necessary approvals before launching pharmaceutical products. Non-compliance can lead to delays in market entry or even rejection of products, hindering business growth and profitability.

· Investor Confidence: Regulatory compliance enhances investor confidence. Investors, whether financial institutions or individual stakeholders, are more likely to support and invest in pharmaceutical businesses that demonstrate a strong commitment to regulatory compliance. Compliance signals responsible business practices, risk management, and a focus on meeting industry standards.

· International Market Expansion: Adhering to regulatory requirements is crucial for expanding into international markets. Many countries have their own regulatory frameworks and standards for pharmaceutical products. By understanding and complying with regulations in their home country, businesses can navigate the complexities of international markets more effectively and establish partnerships with foreign stakeholders.

· Ethical Considerations: Regulatory compliance fosters ethical conduct in the pharmaceutical industry. Compliance with regulations ensures fair competition, prevents the marketing of substandard or counterfeit drugs, and promotes transparency in business operations. Adhering to ethical standards is not only a legal obligation but also a moral responsibility to protect the welfare of patients and the integrity of the industry.

Regulatory Authorities and Framework:

In India, the pharmaceutical industry is governed by several regulatory authorities that oversee the operations and ensure compliance with the relevant laws and regulations.

1. Here are the key regulatory authorities responsible for overseeing pharmaceutical businesses in India:

· Central Drugs Standard Control Organization (CDSCO): CDSCO is the central regulatory authority for pharmaceuticals and medical devices in India. It functions under the purview of the Ministry of Health and Family Welfare. CDSCO is responsible for regulating the import, manufacture, distribution, and sale of drugs and medical devices in the country.

· Drug Controller General of India (DCGI): DCGI is the apex regulatory authority for drugs in India. It operates under the CDSCO and is responsible for granting approvals for clinical trials, manufacturing licenses, and market authorizations for pharmaceutical products. DCGI plays a crucial role in ensuring the safety, efficacy, and quality of drugs in the Indian market.

· State Drug Control Authorities: Each state in India has its own State Drug Control Authority, which operates under the provisions of the Drugs and Cosmetics Act, 1940, and the respective state rules. These authorities are responsible for granting licenses, regulating the sale and distribution of drugs within their jurisdiction, and enforcing compliance with the applicable laws.

2. Regulatory Framework and Primary Legislation:

The regulatory framework for the pharmaceutical industry in India is primarily governed by the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. These laws provide the foundation for regulating the import, manufacture, distribution, and sale of drugs and cosmetics in the country.

· The Drugs and Cosmetics Act, 1940: This act establishes the regulatory framework for drugs and cosmetics in India. It defines various terms, sets out the requirements for manufacturing, sale, and distribution, and provides the legal provisions for regulatory control, inspections, and penalties.

· The Drugs and Cosmetics Rules, 1945: These rules provide detailed regulations and guidelines for implementing the provisions of the Drugs and Cosmetics Act. The rules cover a wide range of aspects, including licensing and registration of manufacturing units, labeling and packaging requirements, import and export regulations, clinical trials, and post-marketing surveillance.

3. Hierarchy of Regulations and Relationship between Central and State Regulatory Bodies:

· The regulatory hierarchy in India follows a central and state division. The central regulatory bodies, such as CDSCO and DCGI, establish and enforce regulations at the national level. They are responsible for granting licenses and approvals for pharmaceutical products and oversee the overall functioning of the industry.

· The state drug control authorities work in coordination with the central regulatory bodies and operate at the state level. They enforce compliance with the laws, issue licenses and registrations within their respective states, and conduct inspections of manufacturing units and pharmacies.

· While the central regulatory bodies lay down the overarching regulations, the state drug control authorities have the power to implement and enforce these regulations within their jurisdictions. The state authorities also have the authority to take action against non-compliant businesses and ensure the safety, efficacy, and quality of drugs in their states.

Licensing and Registration Process:

Starting a pharmaceutical business in India requires obtaining the necessary licenses and registrations to ensure compliance with the regulatory framework. Here are the key licensing and registration requirements for pharmaceutical businesses in India:

1. Manufacturing License:

· A manufacturing license is required for setting up a pharmaceutical manufacturing unit.

· The application process involves submitting Form 24 and the requisite documents to the State Drug Control Authority or the Central Licensing Authority, depending on the nature of the products.

· The required documents may include a detailed manufacturing plan, layout of the premises, proof of possession of premises, appointment of a qualified person, and a fee payment.

· The application is scrutinized, and upon meeting the requirements, the manufacturing license is issued.

2. Wholesale License:

· A wholesale license is necessary for engaging in the wholesale distribution of drugs.

· The application is made to the State Drug Control Authority.

· Required documents typically include a completed application form, proof of premises, a partnership deed or memorandum of association, appointment of a registered pharmacist, and the prescribed fee.

· The authority verifies the documents and, upon approval, issues the wholesale license.

3. Retail License:

· A retail license is needed for operating a pharmacy or retail outlet for the sale of drugs.

· The application is submitted to the State Drug Control Authority.

· The required documents usually include an application form, proof of premises, proof of possession of a registered pharmacist, and the applicable fee.

· After verification, the retail license is issued.

4. Import License:

· An import license is required for importing pharmaceutical products into India.

· The application process involves submitting Form 8 and the necessary documents to the Central Drugs Standard Control Organization (CDSCO).

· The required documents may include an application form, a copy of the purchase order or agreement with the manufacturer, a certificate of analysis, an undertaking for importation for personal use, and the prescribed fee.

· Upon approval, the import license is issued by the CDSCO.

It's important to note that the specific requirements and procedures may vary depending on the nature of the business, location, and other factors. Applicants should consult the respective regulatory authorities and the applicable laws for detailed information.

Associated fees for licenses and registrations vary based on the type of license and the products being dealt with. The fee structure is defined by the respective regulatory authorities and may be subject to periodic revisions. It is advisable to check the official websites of the regulatory authorities or consult with professionals to obtain the latest fee information.

Drug Approval Process:

The process of obtaining approvals for manufacturing and marketing pharmaceutical products in India involves several stages and regulatory requirements. Here is an overview of the drug approval process in India:

1. New Drugs:

· New drugs refer to pharmaceutical products that have not been previously approved and marketed in India.

· The approval pathway for new drugs involves submitting an application to the Drug Controller General of India (DCGI) through the Central Drugs Standard Control Organization (CDSCO).

· The application includes data on preclinical studies, clinical trial results, manufacturing details, and proposed labeling.

· The DCGI evaluates the application based on safety, efficacy, and quality parameters before granting market authorization.

2. Generics:

· Generics are bioequivalent versions of already approved and marketed drugs, with the same active ingredients, dosage form, strength, route of administration, and therapeutic effects.

· The approval pathway for generics involves filing an Abbreviated New Drug Application (ANDA) or a generic drug application.

· The ANDA includes data demonstrating bioequivalence with the reference innovator drug.

· The CDSCO reviews the application and grants approval if the generic drug meets the required standards of bioequivalence, safety, and quality.

3. Over-the-Counter (OTC) Drugs:

· OTC drugs are non-prescription medicines that can be sold directly to consumers without a prescription.

· The approval pathway for OTC drugs involves submitting an application to the CDSCO.

· The application includes data on the safety, efficacy, and quality of the drug, along with labeling and packaging information.

· The CDSCO reviews the application and grants approval if the drug meets the necessary requirements.

Importance of Conducting Clinical Trials:

Clinical trials play a vital role in the drug approval process. They provide essential data on the safety and efficacy of pharmaceutical products, helping regulatory authorities make informed decisions regarding market authorization. Key aspects related to clinical trials and associated regulatory requirements in India include:

· Ethical Approval: Clinical trials must receive approval from an independent ethics committee or Institutional Review Board (IRB) to ensure patient safety and ethical conduct.

· Phases of Clinical Trials: Clinical trials typically involve different phases, including Phase I (safety and dosage determination), Phase II (efficacy and side effects), and Phase III (large-scale efficacy and safety evaluation).

· Clinical Trial Data: Clinical trial data should be generated in compliance with Good Clinical Practices (GCP) guidelines. This includes accurate data collection, monitoring, and reporting of adverse events and the establishment of a data safety monitoring board.

· Regulatory Requirements: The CDSCO has established specific guidelines and regulations for conducting clinical trials in India. These cover aspects such as informed consent, compensation for trial subjects, data management, and trial documentation.

· Post-Marketing Surveillance: After a drug is approved and marketed, post-marketing surveillance helps monitor its safety and effectiveness in real-world settings. Adverse event reporting and pharmacovigilance programs are important aspects of post-marketing surveillance.

Conducting clinical trials in compliance with regulatory requirements ensures patient safety, generates reliable data, and strengthens the credibility of pharmaceutical products. It also helps in obtaining regulatory approvals for manufacturing and marketing drugs in India.

It is important to note that the drug approval process and requirements may undergo updates or revisions. Aspiring pharmaceutical businesses should consult the CDSCO and stay updated with the latest guidelines and regulations applicable to their specific category of drugs.

Intellectual Property Rights (IPR) Protection:

Intellectual property rights play a significant role in the pharmaceutical industry by incentivizing innovation, protecting investments in research and development, and fostering competition. IPR protection encourages pharmaceutical companies to invest in the discovery and development of new drugs, as it grants them exclusive rights to exploit their inventions for a limited period. Here are the key forms of IPR protection available in India:

1. Patents:

· Patents provide exclusive rights to inventors for a limited period (20 years in most cases) and prevent others from making, using, or selling the patented invention without permission.

· In the pharmaceutical sector, patents protect new chemical entities, formulations, manufacturing processes, and therapeutic methods.

· To obtain a patent, the invention must be novel, involve an inventive step, and have industrial applicability.

· The process of filing for and obtaining a patent involves submitting a patent application to the Indian Patent Office, which examines the application for compliance with the patentability criteria.

· The examination process includes a search for prior art, evaluation of novelty and inventive step, and assessment of industrial applicability.

· If the application meets the requirements, the patent is granted, providing exclusive rights to the inventor.

2. Trademarks:

· Trademarks protect distinctive signs, such as brand names, logos, or symbols, that identify and distinguish goods or services in the marketplace.

· In the pharmaceutical industry, trademarks help build brand recognition and prevent the unauthorized use of brand names or logos.

· To obtain trademark protection, an application is filed with the Trademarks Registry in India, accompanied by the necessary fees and supporting documents.

· The application goes through an examination process, where the Registrar determines whether the trademark is distinctive and does not conflict with existing trademarks.

· If the application is accepted, the trademark is registered, granting exclusive rights to use the mark in relation to the designated goods or services.

3. Copyrights:

· Copyrights protect original literary, artistic, and creative works, including research publications, scientific articles, and marketing materials.

· While copyrights are applicable to various forms of content in the pharmaceutical industry, they are particularly relevant in the context of literature and publications.

· Copyright protection arises automatically upon the creation of the work, but registration with the Copyright Office provides additional benefits, such as evidence of ownership and legal protection in case of infringement.

The process of filing for and obtaining patents in the pharmaceutical sector involves technical expertise and adherence to legal requirements. It typically includes the following steps:

a) Filing the Patent Application:

· The patent application is filed with the Indian Patent Office, either online or through physical submission.

· The application includes a description of the invention, claims defining the scope of protection, and supporting documents.

b) Examination and Publication:

· The application undergoes examination by the Patent Office, including a search for prior art and evaluation of patentability.

· If the application meets the patentability criteria, it is published in the Patent Office Journal.

c) Request for Examination:

· Within 48 months from the priority date, a request for examination must be filed with the Patent Office.

· The request triggers the substantive examination of the application.

d) Examination Report and Response:

· The Patent Office issues an examination report, which outlines any objections or deficiencies in the application.

· The applicant has an opportunity to respond to the examination report by addressing the objections and providing arguments or amendments.

e) Grant of Patent:

· If the application is found to be in compliance with the patentability requirements and the objections are satisfactorily addressed, the Patent Office grants the patent.

· Once granted, the applicant has exclusive rights to the patented invention for the designated period.

It is essential for pharmaceutical businesses to understand and protect their intellectual property rights to safeguard their innovations, brand identity, and market advantage. Seeking professional guidance and expertise in IPR protection can help navigate the complex process and ensure the best possible protection for pharmaceutical inventions and assets.

Pricing and Price Control Mechanisms for Starting a Pharma Business in India:

As a start-up pharmaceutical business in India, it is essential to understand the pricing policies and price control mechanisms in place for pharmaceutical products. Here's an overview:

1. National Pharmaceutical Pricing Authority (NPPA):

· The National Pharmaceutical Pricing Authority (NPPA) is the regulatory body responsible for regulating and controlling the prices of pharmaceutical products in India.

· The NPPA operates under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers.

· Its main objective is to ensure the availability of essential drugs at reasonable prices and to monitor the prices of pharmaceutical products.

2. Drug Price Control Orders (DPCOs):

· The Drug Price Control Orders (DPCOs) are issued by the government under the powers conferred by the Essential Commodities Act, 1955.

· The DPCOs regulate the prices of essential drugs and provide guidelines for pricing pharmaceutical products.

· Essential drugs are identified based on their therapeutic importance and the public health needs of the country.

3. Price Control Mechanisms:

· The pricing policies and mechanisms in India include both ceiling prices and market-based pricing.

· Ceiling Prices: The NPPA sets maximum allowable prices (ceiling prices) for essential drugs listed under the DPCOs. These prices cap the maximum retail price that can be charged by pharmaceutical companies for essential drugs.

· Market-Based Pricing: For non-essential drugs not covered under price controls, pharmaceutical companies have the flexibility to set prices based on market dynamics and competition.

4. Price Monitoring and Compliance:

· The NPPA monitors the prices of pharmaceutical products to ensure compliance with pricing regulations.

· Pharmaceutical companies are required to submit pricing and sales data to the NPPA for monitoring purposes.

Role of the National Pharmaceutical Pricing Authority (NPPA):

The NPPA plays a significant role in regulating drug prices and ensuring affordability and accessibility of pharmaceutical products. Its key responsibilities include:

· Fixing Ceiling Prices: The NPPA determines and fixes the ceiling prices for essential drugs listed under the DPCOs. This helps regulate and control the prices of these drugs, making them affordable for the general population.

· Monitoring Compliance: The NPPA monitors the prices of pharmaceutical products to ensure that manufacturers and retailers comply with the pricing regulations and do not charge prices higher than the set ceiling prices.

· Redressing Pricing Grievances: The NPPA addresses complaints and grievances related to overpricing or violations of pricing regulations by pharmaceutical companies. It takes necessary actions to rectify pricing discrepancies and ensure compliance.

· Price Control Review: The NPPA periodically reviews and revises the prices of essential drugs based on market conditions, cost fluctuations, and public health considerations. This helps maintain a balance between affordability and sustainability for pharmaceutical businesses.

Concept of Essential Drugs and Implications of Price Controls:

Essential drugs are medications that are considered necessary for public health and are included in the list of essential medicines published by the World Health Organization (WHO). In India, the concept of essential drugs is closely linked to price controls.

Implications of price controls on pharmaceutical businesses include:

· Pricing Constraints: Pharmaceutical companies must adhere to the ceiling prices set by the NPPA for essential drugs. This can limit pricing flexibility and profit margins for start-up pharmaceutical businesses.

· Affordability and Accessibility: Price controls ensure that essential drugs are available at reasonable prices, making them more affordable and accessible to the general population. This promotes equitable access to essential healthcare.

· Market Competition: Price controls encourage competition among pharmaceutical companies to offer quality products at competitive prices, benefiting consumers. Start-ups can leverage market competition to gain a competitive edge.

· Profitability and Innovation: Price controls may impact the profitability of pharmaceutical businesses, especially if they heavily rely on essential drugs. However, innovation and strategic pricing strategies can help mitigate the impact and create sustainable business models.

· Compliance and Regulatory Challenges: Start-up pharmaceutical businesses need to ensure compliance with pricing regulations and provide accurate pricing and sales data to the NPPA. This requires robust administrative and operational systems.

Understanding the pricing policies and price control mechanisms, as well as complying with the regulations set by the NPPA, is crucial for start-up pharmaceutical businesses in India. It enables them to navigate the pricing landscape, ensure compliance, and build sustainable business models while contributing to affordable and accessible healthcare.

Compliance and Quality Assurance to Start a Pharma Business:

Compliance with Good Manufacturing Practices (GMP) and other quality standards is of paramount importance for starting a pharmaceutical business. Here's why it is crucial:

· Ensuring Product Quality and Safety: Compliance with GMP and quality standards ensures that pharmaceutical products are manufactured, packaged, and stored under controlled conditions, guaranteeing their quality, safety, and efficacy.

· Meeting Regulatory Requirements: Regulatory authorities, such as the Central Drugs Standard Control Organization (CDSCO) in India, enforce stringent regulations related to manufacturing facilities, quality control, and quality assurance. Compliance with these requirements is mandatory to obtain licenses and approvals for manufacturing and marketing pharmaceutical products.

· Building Trust and Reputation: Adhering to GMP and quality standards helps build trust among healthcare professionals, patients, and regulatory bodies. It demonstrates a commitment to producing safe, reliable, and effective pharmaceutical products, which is essential for establishing a positive reputation in the industry.

· Accessing International Markets: Compliance with international quality standards, such as those set by the World Health Organization (WHO) or regulatory bodies in other countries, is often required to access global markets. Meeting these standards expands market opportunities and facilitates international collaborations.

1. Regulatory Requirements related to Manufacturing Facilities, Quality Control, and Quality Assurance:

a) Manufacturing Facilities:

· Pharmaceutical manufacturing facilities must adhere to specific design, layout, and construction requirements to ensure a controlled environment and prevent contamination.

· Facilities should have adequate space, proper ventilation, temperature and humidity controls, and separate areas for various manufacturing processes (e.g., dispensing, production, packaging, storage).

b) Good Manufacturing Practices (GMP):

· GMP guidelines provide a framework for the production and control of pharmaceutical products. They cover aspects such as personnel, equipment, premises, documentation, quality control, and quality assurance.

· Compliance with GMP ensures consistent product quality, batch-to-batch uniformity, and traceability.

c) Quality Control and Quality Assurance:

· Quality Control (QC) involves testing and monitoring pharmaceutical products and raw materials to ensure compliance with quality specifications and standards.

· Quality Assurance (QA) focuses on implementing systems and processes to maintain quality standards throughout the entire manufacturing process, including supplier qualification, process validation, and documentation control.

2. Consequences of Non-Compliance and Significance of Maintaining Quality Standards:

· Regulatory Actions and Penalties: Non-compliance with GMP and quality standards can lead to regulatory actions such as warning letters, product recalls, suspension of manufacturing licenses, or even legal penalties. These actions can severely impact business operations and reputation.

· Compromised Product Quality and Safety: Failure to maintain quality standards increases the risk of producing substandard or adulterated products. This poses significant risks to patient safety, leading to adverse events and loss of trust.

· Reputational Damage: Non-compliance can damage a pharmaceutical business's reputation, resulting in loss of customers, healthcare professional endorsements, and market share. Rebuilding trust and reputation can be a challenging and time-consuming process.

· Competitive Disadvantage: In today's competitive pharmaceutical market, maintaining quality standards provides a competitive edge. Failure to comply with quality requirements can lead to a loss of market opportunities and a competitive disadvantage against compliant competitors.

· Patient Well-being: Ultimately, compliance with quality standards is essential for safeguarding patient well-being. By ensuring that pharmaceutical products meet the required quality, safety, and efficacy standards, businesses contribute to better patient outcomes and overall public health.

Conclusion:

In conclusion, starting a pharmaceutical business in India requires a deep understanding of the regulatory landscape. Here are the key points discussed in this article:

· Significance of Regulatory Compliance: Regulatory compliance plays a crucial role in the pharmaceutical industry, ensuring safety, quality, and legality of products. Understanding the regulatory landscape is essential for aspiring pharmaceutical entrepreneurs.

· Regulatory Authorities and Framework: The regulatory framework in India is overseen by authorities such as the Central Drugs Standard Control Organization (CDSCO) and the Drug Controller General of India (DCGI). The primary legislation governing pharmaceuticals is the Drugs and Cosmetics Act, 1940.

· Licensing and Registration Process: Starting a pharmaceutical business requires obtaining various licenses and registrations, such as manufacturing, wholesale, and import licenses. The process involves submitting necessary documents and paying associated fees.

· Drug Approval Process: Obtaining approvals for manufacturing and marketing pharmaceutical products involves different pathways based on the category of drugs, such as new drugs, generics, and over-the-counter drugs. Clinical trials and regulatory requirements are integral parts of the drug approval process.

· Intellectual Property Rights (IPR) Protection: Intellectual property rights, including patents, trademarks, and copyrights, are crucial in the pharmaceutical industry. Entrepreneurs should understand the process of filing for and obtaining patents to protect their innovations.

· Pricing and Price Control Mechanisms: The National Pharmaceutical Pricing Authority (NPPA) regulates drug prices in India. Essential drugs are subject to price controls, ensuring affordability and accessibility. Start-up businesses must navigate pricing policies and comply with regulations.

· Compliance and Quality Assurance: Compliance with Good Manufacturing Practices (GMP) and quality standards is vital to ensure product quality, meet regulatory requirements, and build trust. Non-compliance can lead to penalties, compromised product quality, and reputational damage.

Aspiring pharmaceutical entrepreneurs should consider the following recommendations:

· Thoroughly research and understand the regulatory requirements and procedures specific to the pharmaceutical industry in India.

· Seek professional guidance and expertise to navigate the complex regulatory landscape effectively.

· Develop robust systems and processes to ensure compliance with GMP and quality standards.

· Invest in the protection of intellectual property rights to safeguard innovations and assets.

· Stay updated with regulatory changes and maintain a proactive approach to compliance.

· Foster a culture of quality and continuous improvement within the organization to ensure product safety and efficacy.

· Build strong relationships with regulatory authorities and participate in industry forums to stay informed about regulatory developments.

By adhering to the regulatory framework, aspiring pharmaceutical entrepreneurs can establish successful businesses that contribute to the healthcare industry while ensuring patient safety and product quality.

Licensing and Registration Requirements for Starting a Pharma Business in India

Choosing the Right Business Structure for Your Pharma Company in India

Essential Skills and Qualifications for Starting a Pharma Business in India

Keywords: list of guidelines for pharma industry, pharmaceutical laws and regulations in India, list of regulatory guidelines for pharmaceuticals, list of regulatory bodies in pharma, government policies for pharmaceutical industry in India, pharma and healthcare regulatory environment in India, Indian pharmacological legal issues, pharmaceutical law courses in India

Tuesday, June 6, 2023

Understanding the Regulatory Landscape for Pharma Businesses in India